Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

1(25%)

Phase Distribution

Ph not_applicable

75%

Ph phase_3

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 3Large-scale testing

1(25.0%)

N/ANon-phased studies

3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Detailed Status

Completed3

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 3

Trials by Phase

Phase 31 (25.0%)

N/A3 (75.0%)

Trials by Status

completed375%

terminated125%

Recent Activity

0 active trials

Showing 4 of 4

completednot_applicable

β-Alanine for Kickboxing Anaerobic Performance

NCT07319052

completednot_applicable

Effectiveness of Qualia NAD+ Supplementation on NAD Levels

NCT06812416

terminatedphase_3

A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics

NCT01644201

completednot_applicable

Oxaloacetate Supplementation for Emotional PMS

NCT03509714

Clinical Trials (4)

Showing 4 of 4 trials

NCT07319052Not Applicable

β-Alanine for Kickboxing Anaerobic Performance

Completed

NCT06812416Not Applicable

Effectiveness of Qualia NAD+ Supplementation on NAD Levels

Completed

NCT01644201Phase 3

A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics

Terminated

NCT03509714Not Applicable

Oxaloacetate Supplementation for Emotional PMS

Completed

All 4 trials loaded

Drug Details

Intervention Type: DIETARY SUPPLEMENT
Total Trials: 4